Loading...
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center Experience
PURPOSE: Dramatic advances in our understanding of the molecular pathophysiology of cancer, along with a rapidly expanding portfolio of molecular targeted drugs, have led to a paradigm shift toward personalized, biomarker-driven cancer treatment. Here, we report the 2-year experience of the Comprehe...
Na minha lista:
| Udgivet i: | JCO Precis Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Clinical Oncology
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7446498/ https://ncbi.nlm.nih.gov/pubmed/32913998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00105 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|